Loading viewer...
investor_presentation
Format: PDF investor_presentation
AltaGas' monthly investor presentation outlining corporate strategy, financial guidance, and operational highlights for 2023. The presentation covers anticipated rate base growth in the Utilities division, midstream strategic priorities, and consolidated normalized EBITDA targets of $1.50-$1.6 billion with normalized EPS of $1.85-$2.05.
investor_presentation
Aegion
BriaCell Therapeutics Investor Presentation 2022
investor_presentationinvestor_presentation
19 Pages
BriaCell Therapeutics Corp.